GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-19.47%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$720M
AUM Growth
+$720M
Cap. Flow
+$227M
Cap. Flow %
31.46%
Top 10 Hldgs %
61.08%
Holding
45
New
11
Increased
13
Reduced
9
Closed
6

Top Buys

1
GBT
Global Blood Therapeutics, Inc.
GBT
$48.4M
2
ZGNX
Zogenix, Inc.
ZGNX
$36.5M
3
BOLD
Audentes Therapeutics, Inc
BOLD
$35.3M
4
PBYI icon
Puma Biotechnology
PBYI
$28.1M
5
ARRY
Array Biopharma Inc
ARRY
$26.4M

Top Sells

1
EXEL icon
Exelixis
EXEL
$36.8M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
$28.5M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$18.9M
4
ARGX icon
argenx
ARGX
$10.6M
5
VYGR icon
Voyager Therapeutics
VYGR
$9.73M

Sector Composition

1 Healthcare 95.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KA
26
DELISTED
Kineta, Inc. Common Stock
KA
$9.87M 1.25%
+3,045,423
New +$9.87M
VYNE icon
27
VYNE Therapeutics
VYNE
$8.09M
$9.08M 1.15%
2,204,407
+900,000
+69% +$3.71M
PTGX icon
28
Protagonist Therapeutics
PTGX
$3.62B
$6.43M 0.81%
955,618
-26,831
-3% -$181K
VYGR icon
29
Voyager Therapeutics
VYGR
$204M
$3.43M 0.43%
365,132
-1,034,868
-74% -$9.73M
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$9.7B
$3.1M 0.39%
27,500
-12,900
-32% -$1.45M
ALNY icon
31
Alnylam Pharmaceuticals
ALNY
$58.6B
$2.93M 0.37%
40,197
-259,803
-87% -$18.9M
ARGX icon
32
argenx
ARGX
$44.2B
$1.78M 0.22%
18,500
-110,560
-86% -$10.6M
VIRX
33
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$132K 0.02%
317,962
-682,038
-68% -$283K
STRM
34
DELISTED
Streamline Health Solutions
STRM
$105K 0.01%
130,137
– –
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-21,441
Closed -$46K
ECYT
36
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-1,606,100
Closed -$28.5M
SRRA
37
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-490,843
Closed -$834K
ICPT
38
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
0
– –
ACER
39
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
– –
-58,461
Closed -$1.8M
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$102B
– –
0
– –
SAGE
41
DELISTED
Sage Therapeutics
SAGE
– –
0
– –
NVAX icon
42
Novavax
NVAX
$1.2B
– –
0
– –
EXEL icon
43
Exelixis
EXEL
$9.95B
– –
-2,075,000
Closed -$36.8M
ZYME icon
44
Zymeworks
ZYME
$1.07B
– –
-241,970
Closed -$3.8M
ITCI
45
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
0
– –
1
2